Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
Clinical trial NCT02022215 · COMPLETED
Trial details
- NCT number
- NCT02022215
- Sponsor
- Meiji Seika Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-19
- Primary completion
- 2015-10-28
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.